Long-term results using old liver grafts for transplantation: Sexagenerian versus liver donors older than 70 years

World Journal of Surgery

Volumn 37, Issue 9, 2013, Pages 2211-2221

  Jiménez Romero, Carlos ^a   Clemares Lama, Marta ^a   Manrique Municio, Alejandro ^a   García Sesma, Alvaro ^a   Calvo Pulido, Jorge ^a   Moreno González, Enrique ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ADULT; AGE; AGED; ALLOGRAFT; BODY MASS; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; COMPLICATION; CONVALESCENCE; DONOR; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PHYSIOLOGY; SUPPLY AND DISTRIBUTION; TRANSPLANTATION; VERY ELDERLY; VIROLOGY; YOUNG ADULT; ARTICLE; DRUG CONTRAINDICATION; LIVER CELL CARCINOMA; LIVER TUMOR; MORTALITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLOGRAFTS; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; RECOVERY OF FUNCTION; SERUM ALBUMIN; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS; YOUNG ADULT;

EID: 84882691136     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2085-7     Document Type: Article

References (65)

1. ONT (2008) Memoria de Actividades de la ONT 2008 (1a Parte). Trasplante hepático. Revista Española de Trasplantes 18:32-50
2. Strasberg SM, Howard TK, Molmenti EP et al (1994) Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 20:829-838
3. Adam R, Sánchez C, Astarcioglu I et al (1995) Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. Transplant Proc 27:1181-1183
4. Ureña MA, Ruiz-Delgado FC, González EM et al (1998) Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 30:3288-3291
5. López-Navidad A, Caballero F (2003) Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 17:308-324
6. Busuttil RW, Tanaka K (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9:651-663
7. Yersiz H, Renz JF, Farmer DG et al (2003) One-hundred in situ split-liver transplantations: a single center experience. Ann Surg 238:496-505
8. Renz JF, Kin C, Kinkhabwala M et al (2005) Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242:556-565
9. Tector AJ, Mangus RS, Chestovich P et al (2006) Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 244:439-450
10. Bernat JL, D'Alessandro AM, Port FK et al (2006) Report of a National Conference on Donation after cardiac death. Am J Transplant 6:281-291
11. Marino IR, Doyle HR, Doria C et al (1995) Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 27:1184-1185
12. Emre S, Schwartz ME, Altaca G et al (1996) Safe use of hepatic allograft from donors older than 70 years. Transplantation 62:62-65
13. Cescon M, Grazi GL, Ercolani G et al (2003) Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable? Liver Transpl 9:1174-1180
14. Anderson CD, Vachharajani N, Doyle M et al (2008) Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 207:847-852
15. Ravaioli M, Grazi GL, Cescon M et al (2009) Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transplant Int 22:423-433
16. Marino IR, Doyle HR, Aldrighetti L et al (1995) Effect of donor age and sex on the outcome of liver transplantation. Hepatology 22:1754-1762
17. Hoofnagle JH, Lombardero M, Zetterman RK et al (1996) Donor age and outcome of liver transplantation. Hepatology 24:89-96
18. Busquets J, Xiol X, Figueras J et al (2001) The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 71:1765-1771
19. Moore DE, Feurer ID, Speroff T et al (2005) Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 140:273-277
20. Grande L, Matus D, Rimola A et al (1998) Expanded liver donor age over 60 years for liver transplantation. Clin Transplant 12:297-301
21. Rodríguez F, Jiménez C, Romano D et al (2002) Orthotopic liver transplantation with 100 hepatic allografts from donors over 60 years old. Transplant Proc 34:233-234
22. Gastaca M, Valdivieso A, Pijoan J et al (2005) Donors older than 70 years in liver transplantation. Transplant Proc 37:3851-3854
23. Zapletal C, Faust D, Wullstein C et al (2005) Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 37:1182-1185
24. Segev DR, Maley WR, Simpkins CE et al (2007) Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 46:1907-1918
25. Jiménez C, Manrique A, Marqués E et al (2007) Incidence and risk factors for the development of lung tumors after liver transplantation. Transplant Int 20:57-63
26. Feng S, Goodrich NP, Bragg-Gresham JL et al (2006) Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6:783-790
27. Rinella ME, Alonso E, Rao S et al (2001) Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 7:409-414
28. Greig PD, Forster J, Superina RA et al (1990) Donor-specific factors predict graft function following liver transplantation. Transplant Proc 22:2072-2073
29. Markin RS, Wisecarver JL, Radio SJ et al (1993) Frozen section evaluation of donor livers before transplantation. Transplantation 56:1403-1409
30. Karayalcin K, Mirza DF, Harrison RF et al (1994) The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation 57:1323-1327
31. García-Ureña MA, Colina F, Moreno E et al (1998) Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 22:837-844. doi: 10.1007/s002689900479
32. Adam R, Astarcioglu I, Azoulay D et al (1991) Age greater than 50 years is not a contraindication for liver donation. Transplant Proc 23:2602-2603
33. D'Alessandro AM, Kalayoglu M, Sollinger HW et al (1991) The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51:157-163
34. Fishbein TM, Fiel MI, Emre S et al (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64:248-251
35. Verran D, Kusyk T, Painter D et al (2003) Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9:500-505
36. Briceño J, Pera-Rojas C, Lluch M et al (2001) Intraoperative assessment of liver transplantation with marginal liver grafts. Transplant Proc 33:903-905
37. Briceño J, Marchal T, Padillo J et al (2002) Influence of marginal donors on liver preservation injury. Transplantation 74:522-526
38. Wall WJ (1999) Predicting outcome after liver transplantation. Liver Transpl Surg 5:458-459
39. Jiménez C, Moreno E, Colina F et al (1999) Use of octogenarian livers safely expands the donor pool. Transplantation 68:572-576
40. Nardo B, Masetti M, Urbani L et al (2004) Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant 4:1139-1147
41. Cescon M, Mazziotti A, Grazi GL et al (2001) Evaluation of the use of graft livers procured from old donors (70 to 87 years) for hepatic transplantation. Transplant Proc 33:934-935
42. Cuende N, Grande L, Sanjuan F et al (2002) Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation 73:1360
43. Kim DY, Cauduro SP, Bohorquez HE et al (2005) Routine use of livers from deceased donors older than 70: is it justified? Transplant Int 18:73-77
44. Fouzas I, Sgourakis G, Nowak KM et al (2008) Liver transplantation with grafts from septuagenarians. Transplant Proc 40:3198-3200
45. Piratvisuth T, Tredger JM, Hayllar KA et al (1995) Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1:296-301
46. Cameron AM, Ghobrial RM, Yersiz H et al (2006) Optimal utilization of donor grafts with extended criteria. A single-center experience in over 1000 liver transplants. Ann Surg 243:748-755
47. Ghobrial RM, Gornbein J, Steadman R et al (2002) Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 236:315-322
48. Berenguer M, Prieto M, San Juan F et al (2002) Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36:202-210
49. Wali M, Harrison RF, Gow PJ et al (2002) Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 51:248-252
50. Russo MW, Galanko JA, Zacks SL et al (2004) Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 4:1133-1138
51. Lake JR, Shorr JS, Steffen BJ et al (2005) Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 5:549-557
52. Condron SL, Heneghan MA, Patel K et al (2005) Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 80:145-148
53. Mutimer DL, Gunson B, Chen J (2006) Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 81:7-14
54. Iacob S, Cicinnati VR, Hilgard P et al (2007) Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. Transplantation 84:56-63
55. Machicao VI, Bonatti H, Krishna M et al (2004) Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 77:84-92
56. Rayhill SC, Wu YM, Katz DA et al (2007) Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 84:331-339
57. Yersiz H, Shaked A, Olthoff K et al (1995) Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 60:790-794
58. Winger DJ, Sponsilli EE (1977) Concentrations of serum protein fractions in white women: effects of age, weight, smoking, tonsillectomy and other factors. Clin Chem 23:1310-1317
59. Shepherd AM, Hewick DS, Moreland TA et al (1977) Age as a determinant of sensitivity to warfarin. Br J Pharmacol 4:315-320
60. Ploeg RJ, D'Alessandro AM, Knechtle SJ et al (1993) Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 55:807-813
61. Mueller AP, Platz KP, Krause P et al (1999) Is the use of marginal liver grafts justified? Transplant Proc 31:401-402
62. Stewart ZA, Locke JE, Segev DL et al (2009) Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors. Liver Transpl 15:1688-1695
63. Deschenes M, Forbes C, Tchervenkov J et al (1999) Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg 5:357-361
64. Busuttil RW, Farmer DG, Yersiz H et al (2005) Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single center experience. Ann Surg 241:905-916
65. Doyle M, Anderson C, Vachharajani N et al (2008) Liver transplantation for hepatitis C virus. Effect of using older donor grafts on short- and medium-term survival. Arch Surg 143:679-685